Skip to main content

Peer Review reports

From: Larotinib in patients with advanced and previously treated esophageal squamous cell carcinoma with epidermal growth factor receptor overexpression or amplification: an open-label, multicenter phase 1b study

Original Submission
17 Jun 2021 Submitted Original manuscript
19 Jul 2021 Reviewed Reviewer Report
24 Jul 2021 Reviewed Reviewer Report
16 Aug 2021 Author responded Author comments - Jianming Xu
24 Sep 2021 Author responded Author comments - Jianming Xu
Resubmission - Version 2
16 Aug 2021 Submitted Manuscript version 2
2 Oct 2021 Reviewed Reviewer Report
14 Oct 2021 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
14 Oct 2021 Editorially accepted
23 Oct 2021 Article published 10.1186/s12876-021-01982-4

You can find further information about peer review here.

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us